SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2013 Biotech Charity Contest
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DewDiligence_on_SI who wrote (44)1/1/2013 1:05:58 PM
From: Biotech Jim1 Recommendation  Read Replies (1) of 410
 
Hey Dew, my main reason for selecting XOMA is primarily due to the Servier collaboration, and no program in particular. My statement was:

"All about the Servier collaboration on gevokizumab and the partner is an expert in ACS"

Here I wanted to point out that Servier in the cardiovascular world is a top notch developer. I have worked with them on a couple of projects in the past, and I know several of the division heads. Servier does not have a great internal pipeline, and that is why it has entered into several collaborations lately. The cardiovascular group is headed by Jean-Paul Vilaine, the person that was key to the discovery and development of both perindopril (long acting ACE inhibitor) and ivabridine (a "funny" channel inhibitor -the channel is highly expressed in the SA node). They always have extensive preclinical data to support clinical development, as the EMEA requires solid preclinical data to support development in a specific indication (FDA not as stringent on the preclinical data requirement but must have plausibility). However, they will be quiet about much of their preclinical data til after Ph 2 efficacy is attained. Nothing better for XOMA than a collaboration partner highly committed to the clinical development plans.

Having said this and seeing this as one of your picks, I look forward to our discussions going forward. :- )

It would have been nice to see a blurb by each entrant as to why they chose their picks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News